Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Asthma”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05155020
What this trial is testing

Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma

Who this might be right for
Asthma
Akeso 1
Post-approval studies (Phase 4)Study completedNCT04203797
What this trial is testing

Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Who this might be right for
Asthma
Regeneron Pharmaceuticals 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05851443
What this trial is testing

Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Who this might be right for
Moderate to Severe Asthma
Incyte Corporation 247
Testing effectiveness (Phase 2)WithdrawnNCT03989635
What this trial is testing

Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.

Who this might be right for
AsthmaAsthma, BronchialBronchial Asthma+2 more
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT03652038
What this trial is testing

Single and Multiple Ascending Dose Study of TD-8236 by Inhalation

Who this might be right for
Asthma
Theravance Biopharma 94
Large-scale testing (Phase 3)Study completedNCT04886999
What this trial is testing

Study in Adult Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 78
Not applicableWithdrawnNCT00853411
What this trial is testing

Asthma Exacerbation Study

Who this might be right for
Asthma
University of Pittsburgh
Testing effectiveness (Phase 2)UnknownNCT06642961
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

Who this might be right for
Asthma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT00314574
What this trial is testing

Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

Who this might be right for
Asthma
Genentech, Inc. 850
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07436221
What this trial is testing

Evaluate the Efficacy and Safety of AK139 in Participants With Asthma

Who this might be right for
Asthma
Akeso 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746687
What this trial is testing

JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

Who this might be right for
Asthma
Janssen Research & Development, LLC 440
Not applicableUnknownNCT02833727
What this trial is testing

Airway Inflammation and Disease Burden in Asthmatic Smokers

Who this might be right for
Asthma
Université de Montréal 160
Testing effectiveness (Phase 2)Study completedNCT01311661
What this trial is testing

Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 206
Testing effectiveness (Phase 2)Study completedNCT05104892
What this trial is testing

Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 196
Testing effectiveness (Phase 2)Ended earlyNCT00787644
What this trial is testing

Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)

Who this might be right for
AsthmaObesity
University of Vermont 28
Large-scale testing (Phase 3)Study completedNCT00180011
What this trial is testing

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
DiMango, Emily, M.D. 18
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Testing effectiveness (Phase 2)Ended earlyNCT02219048
What this trial is testing

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Who this might be right for
Asthma
Pfizer 51
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Post-approval studies (Phase 4)Ended earlyNCT04195958
What this trial is testing

Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Who this might be right for
Moderate-to-severe Allergic Asthma
Genentech, Inc. 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation